EverPoint Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

EverPoint Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-292,200	Closed	-$5.96M	–	570
2015 Q4	$5.96M	Sell	292,200 -282,800	-49%	-$4.36M	0.13%	221
2015 Q3	$7.56M	Buy	575,000 +250,631	+77%	+$4.16M	0.2%	153
2015 Q2	$4.98M	Sell	324,369 -187,334	-37%	-$3.59M	0.09%	276
2015 Q1	$10.2M	Hold	511,703	–	–	0.19%	166
2014 Q4	$10.8M	Buy	511,703 +223,869	+78%	+$4.56M	0.24%	141
2014 Q3	$5.36M	Buy	+287,834	New	+$5.21M	0.12%	239

Other funds holding AGTC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EverPoint Asset Management's AGTC Position: Q1 2016 in Review

EverPoint Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2016, closing a stake of 292,200 shares — an estimated $5.96M sold.

EverPoint Asset Management first reported a position in AGTC in Q3 2014 and held it in 6 quarters. The position peaked at $10.8M in Q4 2014. 90 funds tracked by Wall St. Rank hold AGTC as of Q1 2016.

EverPoint Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2016 after selling out during the quarter.
EverPoint Asset Management sold 292,200 Applied Genetic Technologies Corporation shares in Q1 2016, an estimated $5.96M.
EverPoint Asset Management first reported a position in Applied Genetic Technologies Corporation in Q3 2014 and held it in 6 quarters.
EverPoint Asset Management's Applied Genetic Technologies Corporation position peaked at $10.8M in Q4 2014.
90 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2016.

Based on EverPoint Asset Management's 13F filing for Q1 2016, filed 16 May 2016.